Skip to main content

Table 3 WHO-UMC causality categories

From: The I-MICRO trial, Ilomedin for treatment of septic shock with persistent microperfusion defects: a double-blind, randomized controlled trial—study protocol for a randomized controlled trial

Causality term

Assessment criteria

Certain

• Event or laboratory test abnormality, with plausible time relationship to drug intake

• Cannot be explained by disease or other drugs

• Response to withdrawal plausible (pharmacologically, pathologically)

• Event definitive pharmacologically or phenomenologically (i.e., an objective and specific medical disorder or a recognized pharmacological phenomenon)

• Rechallenge satisfactory, if necessary

Probable/likely

• Event or laboratory test abnormality, with reasonable time relationship to drug intake

• Unlikely to be attributed to disease or other drugs

• Response to withdrawal clinically reasonable

• Rechallenge not required

Possible

• Event or laboratory test abnormality, with reasonable time relationship to drug intake

• Could also be explained by disease or other drugs

• Information on drug withdrawal may be lacking or unclear

Unlikely

• Event or laboratory test abnormality, with time to drug intake

• that makes a relationship improbable (but not impossible)

• Disease or other drugs provide plausible explanations